a Medical Food-Supplemented Detoxification Program in the Management of Chronic Health Problems.
Level 3 - non-randomized controlled study
Non-randomized controlled comparative study
What was done
In an outpatient clinical setting, 106 chronically ill patients received either an oligoantigenic, calorie-controlled diet supplemented with a medical food designed for gastrointestinal healing and hepatic detoxification (n = 84) or the oligoantigenic diet alone (n = 22) for 10 weeks. Symptom changes were tracked using the Metabolic Screening Questionnaire, alongside assessments of hepatic phase I cytochrome P450 activity, phase II glycine conjugation, urinary sulfate-to-creatinine ratio, and intestinal absorption via urinary mannitol excretion.
What was found
Patients in the medical food group achieved a 52% reduction in symptoms over 10 weeks compared to a 22% reduction in the diet-alone group. The intervention group also showed normalization of hepatic phase I to phase II detoxification function, a statistically significant increase in urinary sulfate-to-creatinine ratio, and a marginally significant increase in urinary mannitol excretion. Specific baseline values, standard deviations, and exact p-values were not reported in the abstract.
Why it matters
This study provides preliminary data suggesting that adding targeted nutritional medical foods to an elimination diet may enhance symptom improvement and favorably alter hepatic detoxification markers in chronically ill individuals.
Limits
Allocation was non-randomized with unbalanced group sizes (84 versus 22), creating potential selection bias. Chronic illness conditions were not defined, no blinding or placebo control was utilized, and exact statistical metrics were absent from the abstract.
Cited by
- context In a 1991 study by Jeffrey Bland's group with 80 participants (30 standard of care, 50 on a phytochemical-rich, low-allergen diet), the intervention group had approximately a 60% reduction in symptoms compared to controls over two months.